MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Net comprehensiveloss-$116,159 (83.35%↑ Y/Y)Foreign currencytranslation adjustment$265,862 (3958.10%↑ Y/Y)Change in the fair valueof derivative...$801,038 (24.83%↑ Y/Y)Change in the fair valueof obligation to...$317,527 (-83.12%↓ Y/Y)Net loss-$382,021 (44.68%↑ Y/Y)Total other income(expenses)$300,322 Interest expense$475,617 (-22.73%↓ Y/Y)Imputed interestexpense$311,542 Foreign exchange loss(gain)-$31,084 Loss from operations-$682,343 (-2.19%↓ Y/Y)Gross loss-$409,453 (18.53%↑ Y/Y)Total operatingexpenses$272,890 (65.29%↑ Y/Y)Revenue$627,462 (87.12%↑ Y/Y)Cost of goods sold$1,036,915 (23.75%↑ Y/Y)Royalty expense$131,220 Professional fees$105,856 (-22.36%↓ Y/Y)General andadministrative$35,814 (29.24%↑ Y/Y)
Income Statement
source: myfinsight.com

CANNAPHARMARX, INC. (CPMD)

CANNAPHARMARX, INC. (CPMD)